The global Neuroendocrine Tumor Treatment market size was valued at US$ 2.51 billion in 2020 and is anticipated to grow at a CAGR of 20.4% during forecast period 2021 to 2030.
Increasing cases of neuroendocrine tumors (NETs) are expected to accelerate the demand for treatment options, thereby augmenting the market growth over the forecast period. This is a rapidly advancing field as novel therapies and diagnostic products are being developed. PSMA Targeted PET Imaging Agent by Progenics Pharmaceuticals, Inc. is under the clinical trial phase and is expected to help treat prostate cancer. Heavy investments in the field by cancer research organizations and governments across the globe is another key factor propelling the NET market growth.
Organizations, such as The Neuroendocrine Tumor Research Foundation (NETRF), invested more than USD 1.5 million in the development of advanced radiation therapy named Peptide Receptor Radionuclide Therapy (PRRT). Besides, growing Patient Assistance Programs (PAPs), government initiatives for cancer awareness, and extensive R&D by pharmaceutical companies are expected to propel the market growth in the next few years.
The Somatostatin Analogs (SSAs) and targeted therapy are widely used for the treatment of neuroendocrine carcinoma as they control cancer growth, symptoms, and target biomarkers. SSAs product segment accounted for the largest revenue share as of 2017 owing to the safe treatment procedure offered by SSAs.
SSAs are generally used to treat patients who are resistant to radiation therapy and surgery. Many SSAs are currently under clinical trial phase and waiting for approval. Some of these are PEN-221 by Tarveda Therapeutics and DP1038 by Dauntless Pharmaceuticals.
Targeted therapy consists of drugs, such as Sunitinib and Everolimus. Due to fewer side effects associated with these drugs they are used as the first line of therapy for neuroendocrine carcinoma. The other products include chemotherapy, radiation therapy, surgery, and tyrosine kinase inhibitors.
The small intestine segment accounted for the largest revenue share of the global neuroendocrine tumor treatment market in 2020 as the GI tract is more prone to developing NETs. According to the statistics published in the investor presentation of Novartis in 2015, GI comprises 61% of the total NETs and among them, tumor in the small intestine was the most common one.
Moreover, statistics published by the American Society of Clinical Oncology (ASCO), in 2016, around 8,000 adults in the U.S. have diagnosed with GI tract-carcinid tumors. This increasing prevalence of carcinoid tumors in the GI tract is expected to drive the segment growth over the forecast period.
The pancreas segment is expected to have steady growth during the next few years. Increasing R&D investments for the development of novel therapies for pancreatic NETs are expected to boost the segment expansion. For example, SUNITINIB by Pfizer Inc. is currently under phase III clinical trial and indicated to be used for pancreatic NETs.
The hospital was the dominant end-use segment, in terms of revenue share, in 2020 as a large number of procedures for diagnosis are performed in these facilities. The presence of developed technologies and the availability of multiple options for NET diagnosis are expected to further augment the segment growth.
The clinic segment is expected to witness lucrative growth in the coming years due to the availability of skilled surgeons and patient-centric treatment options. The other segment includes cancer research organizations and government institutes and is likely to offer high growth potential for the NET market in the years to come.
North America accounted for the highest market share in 2020 owing to supportive insurance policies in this region facilitating NET treatment, such as Medicare, Medicaid, and Tricare. Moreover, sophisticated healthcare facilities and high R&D expenditure by pharmaceutical companies and regional government for cancer research are other factors driving the North American market.
Asia Pacific market is anticipated to witness significant growth in the coming years due to the rising incidence of NETs in the region. Increasing investments by the regional governments to tackle the high unmet clinical needs are also likely to help boost market development.
Novartis AG; Boehringer Ingelheim International GmbH; Pfizer, Inc.; and Ipsen Pharma. Several other companies in the market include AVEO Oncology, Hutchison MediPharma Limited, and Progenics Pharmaceuticals.
Somatostatin Analogs (SSAs)
Middle East & Africa
The Neuroendocrine Tumor Treatment market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Neuroendocrine Tumor Treatment market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Neuroendocrine Tumor Treatment market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Neuroendocrine Tumor Treatment market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Neuroendocrine Tumor Treatment market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Neuroendocrine Tumor Treatment capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Neuroendocrine Tumor Treatment by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Neuroendocrine Tumor Treatment market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Neuroendocrine Tumor Treatment market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Neuroendocrine Tumor Treatment market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Neuroendocrine Tumor Treatment industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Neuroendocrine Tumor Treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Neuroendocrine Tumor Treatment market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Neuroendocrine Tumor Treatment market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Neuroendocrine Tumor Treatment market. These factors have benefited the growth of the global market for Neuroendocrine Tumor Treatment. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Neuroendocrine Tumor Treatment. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Neuroendocrine Tumor Treatment are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
Arrhythmia Monitoring Devices Market Size, Share, Growth, Trends, Consumption, Revenue, Company Analysis, Regional Insights and Forecast 2021-2030Read more...
Vaginitis Therapeutics Market Size, Share, Growth, Trends, Consumption, Revenue, Company Analysis, Regional Insights and Forecast 2021-2030Read more...
Botanicals Market Size, Share, Growth, Trends, Consumption, Revenue, Company Analysis, Regional Insights and Forecast 2021-2030Read more...
Stereotactic Surgery Devices Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030Read more...
Biopharmaceuticals Manufacturing Consumables Testing Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030Read more...